Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
171 | Gaceta Mexicana de Oncologia | journal | 0.105 Q4 | 7 | 56 | 143 | 1473 | 20 | 132 | 0.18 | 26.30 | 43.28 | |
170 | Journal of Experimental Therapeutics and Oncology | journal | 0.108 Q4 | 40 | 0 | 5 | 0 | 0 | 4 | 0.00 | 0.00 | 0.00 | |
169 | Current Cancer Therapy Reviews | journal | 0.172 Q4 | 17 | 30 | 100 | 2663 | 61 | 93 | 0.44 | 88.77 | 42.97 | |
168 | International Journal of Cancer Management | journal | 0.198 Q4 | 26 | 61 | 254 | 1829 | 142 | 247 | 0.54 | 29.98 | 46.78 | |
167 | South Asian Journal of Cancer | journal | 0.222 Q4 | 25 | 122 | 161 | 2596 | 103 | 134 | 0.55 | 21.28 | 40.34 | |
166 | Middle East Journal of Cancer | journal | 0.229 Q4 | 11 | 65 | 215 | 1974 | 96 | 212 | 0.45 | 30.37 | 45.22 | |
165 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.234 Q4 | 56 | 338 | 1294 | 12411 | 1247 | 847 | 0.61 | 36.72 | 41.10 | |
164 | Prostate Cancer | journal | 0.305 Q4 | 15 | 2 | 33 | 99 | 37 | 33 | 0.76 | 49.50 | 40.00 | |
163 | Bulletin du Cancer | journal | 0.309 Q4 | 44 | 196 | 600 | 6958 | 472 | 435 | 0.77 | 35.50 | 50.40 | |
162 | Journal of B.U.ON. | journal | 0.340 Q4 | 37 | 0 | 841 | 0 | 973 | 733 | 0.99 | 0.00 | 0.00 | |
161 | Reports of Practical Oncology and Radiotherapy | journal | 0.376 Q4 | 36 | 76 | 426 | 2444 | 565 | 417 | 1.08 | 32.16 | 36.57 | |
160 | Translational Cancer Research | journal | 0.422 Q4 | 39 | 330 | 1735 | 11939 | 2477 | 1667 | 1.46 | 36.18 | 38.43 | |
159 | Infectious Agents and Cancer | journal | 0.424 Q4 | 47 | 78 | 200 | 4349 | 636 | 195 | 3.00 | 55.76 | 51.27 | |
158 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 0.438 Q4 | 59 | 8 | 54 | 659 | 116 | 53 | 1.41 | 82.38 | 47.62 | |
157 | International Journal of Breast Cancer | journal | 0.443 Q4 | 23 | 7 | 48 | 302 | 93 | 48 | 1.76 | 43.14 | 44.74 | |
156 | Current Pathobiology Reports | journal | 0.446 Q4 | 33 | 0 | 27 | 0 | 75 | 27 | 3.71 | 0.00 | 0.00 | |
155 | Tumori | journal | 0.466 Q4 | 59 | 85 | 288 | 2531 | 402 | 270 | 1.45 | 29.78 | 53.79 | |
154 | Molecular and Cellular Oncology | journal | 0.471 Q3 | 37 | 4 | 244 | 155 | 237 | 156 | 0.88 | 38.75 | 41.67 | |
153 | Oncology Research | journal | 0.472 Q3 | 76 | 70 | 174 | 3993 | 354 | 165 | 1.40 | 57.04 | 45.85 | |
152 | Anti-Cancer Drugs | journal | 0.476 Q3 | 102 | 143 | 526 | 4507 | 1045 | 525 | 1.89 | 31.52 | 44.60 | |
151 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.503 Q3 | 108 | 201 | 723 | 12531 | 2011 | 702 | 2.69 | 62.34 | 40.91 | |
150 | ecancermedicalscience | journal | 0.515 Q3 | 47 | 149 | 517 | 4500 | 776 | 517 | 1.17 | 30.20 | 44.86 | |
149 | Oncology Research and Treatment | journal | 0.521 Q3 | 55 | 67 | 283 | 2025 | 448 | 264 | 1.41 | 30.22 | 35.58 | |
148 | International Journal of Biological Markers | journal | 0.528 Q3 | 47 | 27 | 126 | 1051 | 263 | 126 | 2.14 | 38.93 | 42.41 | |
147 | Cancer genetics | journal | 0.530 Q3 | 52 | 46 | 226 | 1458 | 346 | 221 | 1.32 | 31.70 | 49.04 | |
146 | Cancer Informatics | journal | 0.534 Q3 | 37 | 33 | 76 | 1458 | 193 | 74 | 2.64 | 44.18 | 35.56 | |
145 | Journal of the Egyptian National Cancer Institute | journal | 0.537 Q3 | 28 | 43 | 142 | 1859 | 324 | 140 | 1.99 | 43.23 | 42.36 | |
144 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.540 Q3 | 52 | 41 | 103 | 3859 | 252 | 100 | 2.51 | 94.12 | 48.44 | |
143 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.548 Q3 | 65 | 160 | 1295 | 6531 | 1737 | 1261 | 1.13 | 40.82 | 43.46 | |
142 | In Vivo | journal | 0.555 Q3 | 72 | 358 | 1309 | 11933 | 2719 | 1309 | 1.88 | 33.33 | 31.67 | |
141 | Anticancer Research | journal | 0.562 Q3 | 136 | 643 | 2209 | 20559 | 4119 | 2206 | 1.61 | 31.97 | 26.61 | |
140 | Cancer Reports | journal | 0.571 Q3 | 18 | 233 | 424 | 10378 | 804 | 417 | 1.89 | 44.54 | 42.96 | |
139 | Cancer Biomarkers | journal | 0.579 Q3 | 54 | 84 | 404 | 3243 | 958 | 401 | 2.13 | 38.61 | 44.90 | |
138 | Neoplasma | journal | 0.588 Q3 | 57 | 67 | 448 | 51 | 1037 | 448 | 2.01 | 0.76 | 43.23 | |
137 | Mini-Reviews in Medicinal Chemistry | journal | 0.597 Q3 | 107 | 128 | 492 | 14236 | 1903 | 484 | 3.60 | 111.22 | 43.35 | |
136 | Cancer Investigation | journal | 0.604 Q3 | 93 | 83 | 247 | 3668 | 452 | 229 | 1.77 | 44.19 | 39.25 | |
135 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.607 Q3 | 68 | 91 | 285 | 3180 | 871 | 281 | 2.79 | 34.95 | 41.63 | |
134 | Technology in Cancer Research and Treatment | journal | 0.609 Q3 | 72 | 230 | 815 | 11793 | 2100 | 809 | 2.51 | 51.27 | 44.59 | |
133 | Japanese Journal of Clinical Oncology | journal | 0.612 Q3 | 95 | 168 | 661 | 3943 | 1233 | 600 | 1.57 | 23.47 | 21.90 | |
132 | Differentiation | journal | 0.619 Q3 | 107 | 50 | 96 | 3894 | 212 | 93 | 2.17 | 77.88 | 53.61 | |
131 | Nutrition and Cancer | journal | 0.627 Q3 | 130 | 141 | 787 | 7553 | 2249 | 777 | 2.47 | 53.57 | 49.07 | |
130 | Melanoma Research | journal | 0.633 Q3 | 80 | 69 | 249 | 2717 | 440 | 230 | 1.44 | 39.38 | 48.32 | |
129 | Oncology Letters | journal | 0.644 Q3 | 81 | 510 | 2474 | 21927 | 6235 | 2473 | 2.41 | 42.99 | 36.64 | |
128 | Current Cancer Drug Targets | journal | 0.650 Q3 | 103 | 76 | 216 | 5127 | 602 | 211 | 2.34 | 67.46 | 40.55 | |
127 | Nuclear Medicine and Biology | journal | 0.658 Q3 | 98 | 42 | 210 | 1676 | 603 | 200 | 3.15 | 39.90 | 40.13 | |
126 | Breast Cancer: Basic and Clinical Research | journal | 0.662 Q3 | 35 | 20 | 84 | 730 | 221 | 83 | 2.02 | 36.50 | 48.35 | |
125 | European Journal of Cancer Prevention | journal | 0.665 Q3 | 88 | 77 | 236 | 3202 | 477 | 213 | 1.86 | 41.58 | 51.00 | |
124 | Journal of Breast Cancer | journal | 0.671 Q3 | 48 | 48 | 161 | 1908 | 315 | 154 | 2.00 | 39.75 | 45.21 | |
123 | Leukemia Research | journal | 0.694 Q3 | 96 | 123 | 405 | 3859 | 707 | 281 | 1.61 | 31.37 | 43.90 | |
122 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.711 Q3 | 90 | 87 | 334 | 2755 | 645 | 309 | 1.55 | 31.67 | 39.06 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®